BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 24081883)

  • 1. A novel computerized functional assessment for human immunodeficiency virus-associated neurocognitive disorder.
    Rosenthal LS; Skolasky RL; Moxley RT; Roosa HV; Selnes OA; Eschman A; McArthur JC; Sacktor N
    J Neurovirol; 2013 Oct; 19(5):432-41. PubMed ID: 24081883
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Concurrent validity of a computer-based cognitive screening tool for use in adults with HIV disease.
    Becker JT; Dew MA; Aizenstein HJ; Lopez OL; Morrow L; Saxton J
    AIDS Patient Care STDS; 2011 Jun; 25(6):351-7. PubMed ID: 21545295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Utility of a brief computerized battery to assess HIV-associated neurocognitive impairment in a resource-limited setting.
    Yechoor N; Towe SL; Robertson KR; Westreich D; Nakasujja N; Meade CS
    J Neurovirol; 2016 Dec; 22(6):808-815. PubMed ID: 27245592
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preliminary study of a novel cognitive assessment device for the evaluation of HIV-associated neurocognitive impairment.
    Anderson AM; Lennox JL; Nguyen ML; Waldrop-Valverde D; Tyor WR; Loring DW
    J Neurovirol; 2016 Dec; 22(6):816-822. PubMed ID: 27245594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuropsychological Assessment of 412 HIV-Infected Individuals in São Paulo, Brazil.
    Gascón MRP; Vidal JE; Mazzaro YM; Smid J; Marcusso RMN; Capitão CG; Coutinho EM; Benute GRG; De Lucia MCS; de Oliveira ACP
    AIDS Patient Care STDS; 2018 Jan; 32(1):1-8. PubMed ID: 29323557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Screening of mild cognitive impairment in Chinese older adults--a multistage validation of the Chinese abbreviated mild cognitive impairment test.
    Lam LC; Tam CW; Lui VW; Chan WC; Chan SS; Chiu HF; Leung T; Tham MK; Ho KS; Chan WM
    Neuroepidemiology; 2008; 30(1):6-12. PubMed ID: 18204291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Scoring algorithms for a computer-based cognitive screening tool: An illustrative example of overfitting machine learning approaches and the impact on estimates of classification accuracy.
    Ursenbach J; O'Connell ME; Neiser J; Tierney MC; Morgan D; Kosteniuk J; Spiteri RJ
    Psychol Assess; 2019 Nov; 31(11):1377-1382. PubMed ID: 31414853
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Repeatable Battery for the Assessment of Neuropsychological Status as a screening strategy for HIV-Associated Neurocognitive Disorders.
    Costaggiu D; Pinna E; Serchisu L; Barcellona D; Piano P; Ortu F; Marongiu F; Mandas A
    AIDS Care; 2021 Mar; 33(3):357-363. PubMed ID: 32183560
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of the sensitivity, stability, and reliability of three diagnostic schemes for HIV-associated neurocognitive disorders.
    Tierney SM; Sheppard DP; Kordovski VM; Faytell MP; Avci G; Woods SP
    J Neurovirol; 2017 Jun; 23(3):404-421. PubMed ID: 28108972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurological soft signs as a marker of cognitive impairment severity in people living with HIV.
    Toro P; Ceballos ME; Pesenti J; Inostroza M; Valenzuela D; Henríquez F; Forno G; Herold C; Schröder J; Calderón J
    Psychiatry Res; 2018 Aug; 266():138-142. PubMed ID: 29870954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility and validity of the self-administered computerized assessment of mild cognitive impairment with older primary care patients.
    Tierney MC; Naglie G; Upshur R; Moineddin R; Charles J; Jaakkimainen RL
    Alzheimer Dis Assoc Disord; 2014; 28(4):311-9. PubMed ID: 24614274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychiatric symptom burden in older people living with HIV with and without cognitive impairment: the UCSF HIV over 60 cohort study.
    Milanini B; Catella S; Perkovich B; Esmaeili-Firidouni P; Wendelken L; Paul R; Greene M; Ketelle R; Valcour V
    AIDS Care; 2017 Sep; 29(9):1178-1185. PubMed ID: 28127989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for neurocognitive impairment in HIV-positive adults aged 50 years and older: Montreal Cognitive Assessment relates to self-reported and clinician-rated everyday functioning.
    Fazeli PL; Casaletto KB; Paolillo E; Moore RC; Moore DJ; The Hnrp Group
    J Clin Exp Neuropsychol; 2017 Nov; 39(9):842-853. PubMed ID: 28122474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of three cognitive exams in cardiac arrest survivors.
    Koller AC; Rittenberger JC; Repine MJ; Morgan PW; Kristan J; Callaway CW;
    Resuscitation; 2017 Jul; 116():98-104. PubMed ID: 28511984
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The neuropsychological and neurological impact of hepatitis C virus co-infection in HIV-infected subjects.
    Clifford DB; Evans SR; Yang Y; Gulick RM
    AIDS; 2005 Oct; 19 Suppl 3():S64-71. PubMed ID: 16251830
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluating the accuracy of self-report for the diagnosis of HIV-associated neurocognitive disorder (HAND): defining "symptomatic" versus "asymptomatic" HAND.
    Obermeit LC; Beltran J; Casaletto KB; Franklin DR; Letendre S; Ellis R; Fennema-Notestine C; Vaida F; Collier AC; Marra CM; Clifford D; Gelman B; Sacktor N; Morgello S; Simpson D; McCutchan JA; Grant I; Heaton RK;
    J Neurovirol; 2017 Feb; 23(1):67-78. PubMed ID: 27557777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific amino acids in HIV-1 Vpr are significantly associated with differences in patient neurocognitive status.
    Dampier W; Antell GC; Aiamkitsumrit B; Nonnemacher MR; Jacobson JM; Pirrone V; Zhong W; Kercher K; Passic S; Williams JW; James T; Devlin KN; Giovannetti T; Libon DJ; Szep Z; Ehrlich GD; Wigdahl B; Krebs FC
    J Neurovirol; 2017 Feb; 23(1):113-124. PubMed ID: 27400931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. How helpful are the European AIDS Clinical Society cognitive screening questions in predicting cognitive impairment in an aging, well-treated HIV-positive population?
    Metral M; Nadin I; Locatelli I; Tarr PE; Calmy A; Kovari H; Brugger P; Cusini A; Gutbrod K; Schmid P; Schwind M; Kunze U; Di Benedetto C; Pignatti R; Du Pasquier R; Darling K; Cavassini M;
    HIV Med; 2020 May; 21(5):342-348. PubMed ID: 31883203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of practice effect on neuropsychological measures among persons with and without HIV infection in northern India.
    Ownby RL; Waldrop-Valverde D; Jones DL; Sharma S; Nehra R; Kumar AM; Prabhakar S; Acevedo A; Kumar M
    J Neurovirol; 2017 Feb; 23(1):134-140. PubMed ID: 27739034
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurocognitive outcomes following successful resuscitation from cardiac arrest.
    Sabedra AR; Kristan J; Raina K; Holm MB; Callaway CW; Guyette FX; Dezfulian C; Doshi AA; Rittenberger JC;
    Resuscitation; 2015 May; 90():67-72. PubMed ID: 25737082
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.